3/19
08:00 am
tndm
Tandem Diabetes Care (TNDM) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $35.00 price target on the stock, up from $27.00.
Low
Report
Tandem Diabetes Care (TNDM) was upgraded by Truist Financial Corporation from "hold" to "buy". They now have a $35.00 price target on the stock, up from $27.00.
3/17
08:00 am
tndm
Tandem Diabetes Care (TNDM) was upgraded by Piper Sandler from "neutral" to "overweight". They now have a $33.00 price target on the stock.
Medium
Report
Tandem Diabetes Care (TNDM) was upgraded by Piper Sandler from "neutral" to "overweight". They now have a $33.00 price target on the stock.
3/16
06:39 am
tndm
1 Surging Stock with Impressive Fundamentals and 2 Facing Challenges [Yahoo! Finance]
Low
Report
1 Surging Stock with Impressive Fundamentals and 2 Facing Challenges [Yahoo! Finance]
3/15
10:29 am
tndm
Assessing Tandem Diabetes Care (TNDM) Valuation After Android Expansion For Tandem Mobi [Yahoo! Finance]
Low
Report
Assessing Tandem Diabetes Care (TNDM) Valuation After Android Expansion For Tandem Mobi [Yahoo! Finance]
3/15
03:17 am
tndm
How Investors Are Reacting To Tandem Diabetes Care (TNDM) Expanding Mobi Control To Android Smartphones [Yahoo! Finance]
Low
Report
How Investors Are Reacting To Tandem Diabetes Care (TNDM) Expanding Mobi Control To Android Smartphones [Yahoo! Finance]
3/15
02:22 am
tndm
Tandem Diabetes Android Launch Expands Access And Shapes TNDM Valuation Story [Yahoo! Finance]
Low
Report
Tandem Diabetes Android Launch Expands Access And Shapes TNDM Valuation Story [Yahoo! Finance]
3/4
11:55 pm
tndm
Tandem Mobi Android Launch Expands Access And Supports Recurring Revenue Story [Yahoo! Finance]
Low
Report
Tandem Mobi Android Launch Expands Access And Supports Recurring Revenue Story [Yahoo! Finance]
3/4
05:22 pm
tndm
Tandem Mobi Now Compatible with Android Smartphones [Yahoo! Finance]
Medium
Report
Tandem Mobi Now Compatible with Android Smartphones [Yahoo! Finance]
3/4
05:00 pm
tndm
Tandem Mobi Now Compatible with Android Smartphones
Medium
Report
Tandem Mobi Now Compatible with Android Smartphones
3/3
10:03 am
tndm
3 Healthcare Stocks We're Skeptical Of [Yahoo! Finance]
Low
Report
3 Healthcare Stocks We're Skeptical Of [Yahoo! Finance]
3/2
12:36 pm
tndm
Tandem Diabetes Care (TNDM) had its price target raised by Morgan Stanley from $23.00 to $25.00. They now have an "equal weight" rating on the stock.
Low
Report
Tandem Diabetes Care (TNDM) had its price target raised by Morgan Stanley from $23.00 to $25.00. They now have an "equal weight" rating on the stock.
3/1
11:56 pm
tndm
Tandem Diabetes Care Conference: Record 58% Margin, “Toby” Tubeless Mobi and Pharmacy Shift Ahead [Yahoo! Finance]
Low
Report
Tandem Diabetes Care Conference: Record 58% Margin, “Toby” Tubeless Mobi and Pharmacy Shift Ahead [Yahoo! Finance]
2/25
12:30 am
tndm
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
Low
Report
Tandem Diabetes Care Prices Upsized Private Placement of $265 Million of Convertible Senior Notes Due 2032
2/23
04:05 pm
tndm
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
Low
Report
Tandem Diabetes Care Announces Proposed Private Placement of Convertible Notes
2/23
12:05 pm
tndm
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition [Seeking Alpha]
Medium
Report
Tandem Diabetes Care: Strong Q4 Execution Amid A PayGo Transition [Seeking Alpha]
2/23
08:59 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $27.00 price target on the stock, up previously from $24.00.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "hold" rating reaffirmed by analysts at Truist Financial Corporation. They now have a $27.00 price target on the stock, up previously from $24.00.
2/23
08:03 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Lake Street Capital from a "hold" rating to a "buy" rating.
2/23
07:17 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
2/23
07:01 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "overweight" rating reaffirmed by analysts at Barclays PLC.
2/20
10:01 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) was given a new $22.00 price target on by analysts at Mizuho.
Medium
Report
Tandem Diabetes Care (NASDAQ:TNDM) was given a new $22.00 price target on by analysts at Mizuho.
2/20
09:36 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "hold" rating on the stock.
Medium
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its price target raised by analysts at Stifel Nicolaus from $20.00 to $22.00. They now have a "hold" rating on the stock.
2/20
08:06 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
2/20
08:03 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $30.00 price target on the stock, up previously from $15.00.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) was upgraded by analysts at Bank of America Corporation from an "underperform" rating to a "neutral" rating. They now have a $30.00 price target on the stock, up previously from $15.00.
2/20
07:18 am
tndm
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
High
Report
Tandem Diabetes Care (NASDAQ:TNDM) had its "neutral" rating reaffirmed by analysts at Piper Sandler.
2/20
12:16 am
tndm
Tandem Diabetes Care Inc (TNDM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]
High
Report
Tandem Diabetes Care Inc (TNDM) Q4 2025 Earnings Call Highlights: Record Sales and Strategic ... [Yahoo! Finance]